GlobeNewswire

Resilinc study: 32% of the S&P 500 impacted in 2017

Share

Resilinc Publishes 2017 EventWatch® Supply Chain Disruption Annual Report

SAN FRANCISCO, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Resilinc, a global provider of supply chain resiliency solutions, released its 2017 EventWatch® Supply Chain Disruption Annual Report today.  The report identifies that global supply chain disruptions roughly doubled in the past year, potentially impacting 32% of S&P 500 company's supply chains and negatively effecting the US economy.

In 2017, natural disasters and weather-related events proved to be a considerable source of disruption across the globe and especially the United States, which for the first time became the most impacted region in the world.  In addition to natural disasters, factory fires remain a significant risk to supply chains, and cyber-attacks increased substantially in 2017.

The annual report is a study of the prior year's supply chain disruption events: natural disasters, extreme weather, fires, environmental hazards, geopolitical occurrences, and other business developments.  These events are tracked and their impact upon manufacturing supply chains assessed by the Resilinc technology and expert teams.  The Resilinc EventWatch® service provides 24x7 alerting and notifications to subscribers tracking their exposure.  Hundreds of millions of news alerts across over 100,000 sources in 44 languages were monitored and analyzed in 2017 alone.

"This should be a wake-up call for business leaders around the globe," states Bindiya Vakil, CEO of Resilinc.  "2017 was a turbulent year for US companies and their supply chains, causing a hidden drag that must be addressed.  With 32% of S&P 500 companies potentially impacted, the economic damage is enormous."  Hurricanes Harvey, Irma, and Maria alone contributed to significant impacts to business in 2017, finds the report. 

In 2017, Resilinc EventWatch contacted more than 19,000 unique suppliers for potential impacts, which generated responses from 53% of those suppliers contacted.  "When an event occurs, action must be taken by all members of the supply chain, to ensure that appropriate steps are taken to avoid any potential impacts.  The faster and more efficiently these steps are taken, the less the overall economic consequences," said Shahzaib Khan, Director of EventWatch at Resilinc.

The annual report analyzed incidents by risk type, industry, geography, disruption potential, and month for 2016 and 2017 for comparison purposes by industry and geography.  The report highlights global supply chain risk trends through a variety of lenses and aids supply chain planning for 2018 and beyond.

Key report highlights include:

  • The top 5 events of 2017 in terms of impact to businesses were:
    1. Late winter storm in the Northeast USA, March
    2. Weather related damage closed the US/Mexico Laredo border, May
    3. Hurricane Harvey in USA, August
    4. Hurricane Irma in USA, September
    5. Hurricane Maria in Puerto Rico, September 
  • For the first time, North America was the most disrupted region by natural disasters.
  • Factory fire/explosion represented the majority of EventWatch bulletins in 2017 with 18% of bulletins notified.
  • Cyber-attacks increased substantially, particularly of the ransomware variety.
  • The automotive industry was the most disrupted industry as it saw an increase of 30% bulletins published. All industries observed increases of around 300 bulletins or greater in 2017.

For more information
An electronic version of the annual report is available at http://info.resilinc.com/eventwatch-2017-annual-report-0

The Resilinc EventWatch service is available at https://info.resilinc.com/eventwatch-professional-enterprise

About Resilinc
Resilinc is the leading global supplier of supply chain risk and resiliency solutions.  Industry leading companies such as IBM, General Motors, EMC, Amgen and Western Digital rely on Resilinc to plan for potential supply chain failures, and to protect revenue despite supply chain disruptions worldwide.  For more information about our solutions, please visit www.resilinc.com.

Contact:

Grover Righter, Chief Marketing Officer

Marketing.Team@Resilinc.com

 




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Resilinc via Globenewswire

About GlobeNewswire

GlobeNewswire



Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Karolinska Development delays publication of its Annual Report for 2018 and changes date for the Annual General Meeting26.4.2019 08:00:00 CESTPress release

STOCKHOLM, SWEDEN - 26 April 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that The Board of Directors has decided to delay the publication of its Annual Report for 2018. Karolinska Development has changed the date for the Annual General Meeting to June 26, 2019. The date for publication of the Annual Report for 2018 has been changed from April 26 to April 30, 2019. Karolinska Development has changed the date for the Annual General Meeting from June 4 to June 26, 2019. Notice to the Annual General Meeting will be published in a separate press release. For more information, please contact: Viktor Drvota, CEO, Karolinska Development AB Phone: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com Fredrik Järrsten, CFO, Karolinska Development AB Phone: +46 70 496 46 28, e-mail: fredrik.jarrsten@karolinskadevelopment.com TO THE EDITORS About Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences investmen

Karolinska Development senarelägger publicering av årsredovisningen för 2018 och meddelar nytt datum för årsstämma26.4.2019 08:00:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 26 april 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att styrelsen har beslutat att senarelägga publiceringen av årsredovisningen för 2018. Karolinska Development har ändrat datum för årsstämman till den 26 juni 2019. Publiceringen av årsredovisningen för 2018 flyttas från den 26 april till den 30 april 2019. Karolinska Development har ändrat datum för årsstämman från den 4 juni till den 26 juni 2019. Kallelse till årsstämman kommer att publiceras senare i ett separat pressmeddelande. För ytterligare information, vänligen kontakta: Viktor Drvota, vd, Karolinska Development AB Tel: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com Fredrik Järrsten, finanschef, Karolinska Development AB Tel: +46 70 496 46 28, e-mail: fredrik.jarrsten@karolinskadevelopment.com TILL REDAKTÖRERNA Om Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) är ett nordiskt investmentbolag inom life science. Bolaget fokuserar p

Karolinska Developments portföljbolag Aprea Therapeutics har fått särläkemedelsstatus och snabbspårstatus från FDA för APR-24616.4.2019 12:46:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 16 april 2019. Karolinska Development AB meddelar idag att portföljbolaget Aprea Therapeutics har av FDA fått särläkemedelsstatus för APR-246 för behandling av patienter med TP53-muterad myelodysplastiskt syndrom (MDS). Dessutom ger FDA bolaget snabbspårstatus (Fast Track Designation), för APR-246 för behandling av MDS. Amerikanska läkemedelsverket, FDA, ger särläkemedelsstatus till läkemedelskandidater för att snabba på utvärderingen och utvecklingen av säkra och effektiva behandlingar av ovanliga sjukdomar. Särläkemedelsstatus ger företag både regulatoriska och kommersiella incitament genom att läkemedlet får marknadsexklusivitet på den amerikanska marknaden i sju år efter marknadsgodkännande samtidigt som företaget får stöd från FDA när det gäller designen av kliniska prövningar, skatteförmåner för kostnader kopplade till kliniska prövningar och avgiftsbefrielse från FDA. FDA:s snabbspår underlättar utvecklingen av läkemedel som är avsedda för att behandla allva

Karolinska Development's portfolio company Aprea Therapeutics has received FDA Orphan Drug Designation and Fast Track Designation for APR-24616.4.2019 12:46:00 CESTPress release

STOCKHOLM, April 16, 2019. Karolinska Development's portfolio company Aprea Therapeutics has from FDA received an Orphan Drug Designation for APR-246 for the treatment of patients with Myelodysplastic Syndromes (MDS) having a TP53 mutation. In addition, FDA has also granted Fast Track Designation to APR-246 for treatment of MDS. Orphan Drug Designation is granted by the FDA Office of Orphan Products Development to advance the evaluation and development of safe and effective therapies for the treatment of rare diseases. The designation can provide development and commercial incentives for designated compounds and medicines, including eligibility for a seven-year period of market exclusivity in the U.S. after product approval, FDA assistance in clinical trial design, tax credits related to clinical trial expenses, and an exemption from FDA user fees. The FDA's Fast Track program facilitates the development of drugs intended to treat serious conditions and that have the potential to addre

Bergman & Beving AB: Bergman & Beving förvärvar KGC10.4.2019 14:00:00 CESTPressmeddelande

Pressmeddelande Bergman & Beving förvärvar KGC Bergman & Beving har idag tecknat avtal om förvärv av samtliga aktier i KGC Verktyg & Maskiner AB. KGC, med säte i Älvsjö, har i mer än 60 år utvecklat och levererat kvalitetsverktyg och tillbehör för murning och plattsättning i det egna varumärket KGC. Bolaget omsätter cirka 80 MSEK per år, och har 24 anställda. "KGC är ett ledande varumärke med högt anseende hos murare och plattsättare och har en mycket stark ställning på den svenska marknaden", säger Pontus Boman, VD och koncernchef. Tillträde beräknas ske den 1 maj 2019 och förvärvet bedöms ha en marginellt positiv påverkan på Bergman & Bevings resultat per aktie under innevarande räkenskapsår. Stockholm den 10 april 2019 Bergman & Beving AB (publ) För ytterligare information kontakta: Pontus Boman, VD & Koncernchef, telefon 010-454 77 00 Peter Schön, CFO, telefon 070-339 89 99 Denna information lämnades, genom ovanstående kontaktpersoners försorg, för offentliggörande den 10 april 201

Bergman & Beving AB: Bergman & Beving acquires KGC10.4.2019 14:00:00 CESTPress release

Press release Bergman & Beving acquires KGC Bergman & Beving has today signed an agreement to acquire all shares in KGC Verktyg & Maskiner AB. KGC, based in Älvsjö, has for more than 60 years developed and delivered quality tools and accessories for bricklayers and tilers in its own brand KGC. The business has a turnover of approximately SEK 80 million per year, and has 24 employees. "KGC is a leading brand with high reputation among bricklayers and tilers and has a very strong position in the Swedish market," says Pontus Boman, President and CEO. The closing is taking effect on 1 May 2019 and the acquisition is expected to have a marginal positive impact on Bergman & Beving's earnings per share during the current fiscal year. Stockholm, 10 April 2019 Bergman & Beving AB (publ) For further information, please contact: Pontus Boman, President & CEO, Tel: +46 10 454 77 00 Peter Schön, CFO, Tel: +46 70 339 89 99 The information was submitted for publication, through the agency of the cont

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom